The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH AL 2018 | Involving the patient is a key part of cancer treatment
In this interview, Mark Levis, MD, PhD, of Sidney Kimmel Comprehensive Cancer Centre, Baltimore, MD, discusses the importantance of involving the patient in the treatment decision-making process. Dr Levis emphasizes the need to not only educate physicians on the newest treatment options, but also the patient, in order to make informed disease management decisions together. It is also important to remember that when choosing the risker treatment options, physicians may question themselves and can also need support too. This interview was recorded at the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary.
